Haru Morita, President and CEO of Modalis Therapeutics Corporation, is scheduled to give a speech regarding
“The frontline of Gene editing and Modalis’ novel gene modulation therapies”
at the LINK-J Symposium “The Frontiers of Drug Discovery” hosted by Life Science Innovation Network Japan (LINK-J) on June 18.

For more details, please see the following link.